On May 31, the IE Healthcare Club hosted Sergey Gorbatov, former IE student, current IE adjunct professor, and Development Director of Abbvie Pharmaceuticals. Sergey was able to provide us with valuable insight into leadership opportunities in the pharma industry thanks to his experience in HR across a variety of companies.
Sergey began his talk with the most important element of the industry: the patient. Abbvie is committed to patient-centered development and this mindset is crucial to leadership, research, and development in the company. Abbvie focuses in bio-pharma and seeks to tackle some of the most serious health issues such as liver disease and cancer. Particularly exciting are Abbvie’s current investments in an all-oral interferon-free treatment for hepatitis C and difficult-to-treat cancers such as multiple myeloma.
An interesting insight Sergey shared with us was to look for companies that invest in drugs for rare and hard-to-treat diseases. These so-called “orphan drugs” are a good indicator of a company’s innovation environment and future viability, Sergey explained. While it may seem counter-intuitive to seek leadership opportunities in big pharma, companies like Abbvie that prove their commitment to R&D and encourage idea-sharing at all levels of the organization can deliver results and make a powerful impact in patients’ lives.
Students from the IMBA, MIM, and Big Data programs attended and participated in the discussion followed by an informal networking event with Sergey.